HOME >> BIOLOGY >> NEWS
Georgia Tech computer program designed to halt pandemics installed in Georgia

Your city has 48 hours to vaccinate every man, woman and child to prevent a dangerous pandemic. Where do you put the clinics, how many health care workers will you need and how do you get 2 million people to a finite number of emergency clinics?

The logistics of handling all those panicked people, health care workers, vaccinations, clinics and forms are dizzying. And while health departments have plans in place, it's very difficult to know how well those plans will perform when time is critical and the minutes needed to move patients to a large clinic or for a frightened patient to fill out a form could mean life or death for thousands or millions of people.

Now researchers at Georgia Tech have developed a computer program, based on a clinical model created by the Centers for Disease Control and Prevention (CDC), to help U.S. state, city and county health care departments create and test more efficient plans for treating infectious illness, whether it's a natural or man-made outbreak.

The program, called RealOpt and created by Dr. Eva Lee, an associate professor of industrial and systems engineering at the Georgia Institute of Technology, will be installed over the next few months at health departments across the state of Georgia and health departments in 35 other states have plans to test the program. While the program is still in the testing phase, it will soon be available free to any government health department that requests it from Georgia Tech.

RealOpt has been tested by the DeKalb County Health Department in Georgia, and the county ran a very successful anthrax drill last year. Lee used RealOpt to help DeKalb test and improve its existing bioterror preparedness plan.

RealOpt takes the numerous variables associated with a health care department's treatment of a very large group of people, and through large-scale simulation and optimization (even considering variables such as panic and language barriers), pinpoints th
'"/>

Contact: Megan McRainey
megan.mcrainey@icpa.gatech.edu
404-894-6016
Georgia Institute of Technology
20-Apr-2006


Page: 1 2 3

Related biology news :

1. Educators in Georgia and Maryland earn top 2006 Mentoring Awards from AAAS
2. Nature meets technology at Georgia Techs conference on bio-inspired design
3. New Georgia Tech probe revolutionizes nano imaging
4. Georgia Tech develops technology for more compact, inexpensive spectrometers
5. Georgia Tech accelerates drug discovery with new IBM supercomputing cluster
6. Georgia Tech study: Short glass shapes cause over-pouring of alcohol
7. Are hurricanes increasing? Ask a Georgia pine tree
8. Georgia Tech develops mass spectrometry device that analyzes proteins faster and at a lower cost
9. NIH awards Georgia Tech/Emory $11.5 M for nano cardiology research
10. Georgia Tech research reveals how biomaterial properties control cellular responses
11. Georgia Tech research indicates immune complications associated with combination medical devices

Post Your Comments:
(Date:3/12/2015)... 12, 2015 Beta Systems ... and access management (IAM) solution for a fixed ... Beta System,s new IAM package, customers benefit from ... from multiple IAM implementations across different industries. The ... well as any necessary services and consulting. It ...
(Date:3/11/2015)... Mar. 11, 2015 Research and Markets ... "Access Control Market by Product, Application & By ... report to their offering. , This report ... reach $10.4 billion by 2020, with an estimated CAGR ... covers the products types such as contact cards & ...
(Date:3/10/2015)... NEW YORK , March 10, 2015  Continuing ... and the Unexpected, Hammacher Schlemmer introduces The Eye ... user,s identity before granting access to secure websites or ... trusted to verify travelers at international borders, the device ... 240 distinctive pattern points of the iris, converting them ...
Breaking Biology News(10 mins):Beta Systems Fast Forward IAM Available Now: a Standardized IAM Package at a Fixed Price 2Global Access Control (Cards & Readers, Biometrics, Controllers, Management Software) Market 2015-2020 - Analysis of the $10 Billion Market 2Hammacher Schlemmer Introduces The Eye Scanning Password Authenticator 2
(Date:3/26/2015)... ReliantHeart, Inc., an innovative supplier of advanced mechanical ... transit-time flow measurement solutions, are collaborating on a miniature ... the HeartAssist5® Left Ventricular Assist Device (LVAD). ... and peace of mind. , The Transonic flow ... 1/6th of the power required by earlier flow board ...
(Date:3/25/2015)... 26, 2015 Agnition announced today that ... American Farmer, airing for the first time at 7:30 ... American Farmer will explore the extremely important role soil ... with a patented Microbial Catalyst™ technology that enhances soil ... The segment will air again on April 28. , ...
(Date:3/25/2015)... (PRWEB) March 25, 2015 Laboratory ... Top-Loading Balances and Analytical Balances to get best-performing ... line of weighing balances from the trusted brand ... Balances increase your efficiency by providing a ... of samples. Weighing modes include parts counting, percent ...
(Date:3/25/2015)... Francisco, CA (PRWEB) March 25, 2015 ... Support for Novel Mechanism of Action in Neuromuscular ... 25, 2015 – Cytokinetics, Incorporated (Nasdaq: CYTK) announced ... fast skeletal muscle troponin activator tirasemtiv in the ... a Phase IIa “Evidence of Effect” or hypothesis-generating ...
Breaking Biology Technology:LVAD patients to have greater mobility and peace of mind through Transonic and ReliantHeart’s True Flow collaboration for the HeartAssist5® 2LVAD patients to have greater mobility and peace of mind through Transonic and ReliantHeart’s True Flow collaboration for the HeartAssist5® 3Agnition to be Featured In Upcoming Episode of American Farmer on RFD-TV 2New Economical Top-Loading and Analytical Symmetry Balances from Cole-Parmer 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 3Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 4Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 5Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 6
Cached News: